
Integrating Metabolomics and Polygenics with SCORE2: A New Frontier in Cardiovascular Risk Stratification
A large-scale UK Biobank study demonstrates that combining NMR metabolomics, polygenic risk scores, and clinical biomarkers with SCORE2 significantly enhances cardiovascular risk prediction, potentially doubling the number of prevented even






